An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies-Reference-Cited by-同舟云学术

An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Published:2018-02-20 Issue:9 Volume:32 Page:1970-1983
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Cooper Matthew L,Choi Jaebok^ORCID,Staser Karl,Ritchey Julie K,Devenport Jessica M,Eckardt Kayla,Rettig Michael P,Wang Bing,Eissenberg Linda G,Ghobadi Armin,Gehrs Leah N,Prior Julie L,Achilefu Samuel,Miller Christopher A^ORCID,Fronick Catrina C,O’Neal Julie,Gao Feng,Weinstock David M,Gutierrez Alejandro^ORCID,Fulton Robert S,DiPersio John F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0065-5.pdf

Reference42 articles.

1. Ma H, Abdul-Hay M. T-cell lymphomas, a challenging disease: types, treatments, and future. Int J Clin Oncol. 2017;22:18–51.

2. Karrman K, Johansson B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2017;56:89–116.

3. Gökbuget N, Arnold R, Böhme A, Fietkau R, Freund M, Ganser A. et al. Treatment of adult ALL according to protocols of the German Multicenter Study Group for adult ALL (GMALL). Editors: Estey EH, Faderl SH, Kantarjian HM. Acute leukemias. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 167–76.

4. Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, DeWald G, et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood. 2009;114:5136–45.

5. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, et al. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol. 2003;21:3616–22.

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03

2. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia;2024-09-03

3. T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers;Molecular Therapy: Oncology;2024-09

4. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

5. Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial;2024-08-05